Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
Ontology highlight
SUBMITTER: Choi SH
PROVIDER: S-EPMC11337916 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA